✦ LIBER ✦
Early experience with CGP 4718 A (Sercloremine), a new selective and reversible MAO-A and 5-HT-uptake inhibitor, in the treatment of depressive patients
✍ Scribed by A. Delini-Stula; R. Fischbach; F. Gnirss; E. Bures; W. Pöldinger
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 654 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.